Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Randomized Double-blind Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Recombinant Monkeypox Protein Vaccine JT118 in Healthy Adults.

NCT07495202 is registered in ClinicalTrials.gov with Shanghai JunTop Biosciences Co., LTD as lead sponsor.

NCT NCT07495202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07495202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Randomized Double-blind Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Recombinant Monkeypox Protein Vaccine JT118 in Healthy Adults.
Lead sponsor
Shanghai JunTop Biosciences Co., LTD
Phase
Phase 1
Overall status
Recruiting
Start date
May 18, 2026
Completion date
November 7, 2027
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

health volunteer